Summary of all the Indicators
Overall Consensus
Sell
6Bullish
1Neutral
12Bearish
Technical Analysis Consensus
Sell
2Bullish
1Neutral
4Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Adaptimmune Therapeutics’s (473A) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Adaptimmune Therapeutics is a Sell.
Adaptimmune Therapeutics’s (473A) 20-Day exponential moving average is 0.01, while Adaptimmune Therapeutics’s (473A) share price is <€0.1, making it a Sell.
Adaptimmune Therapeutics’s (473A) 50-Day exponential moving average is 0.01, while Adaptimmune Therapeutics’s (473A) share price is <€0.1, making it a Sell.
Adaptimmune Therapeutics (473A) Pivot Points
Classic
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Fibonacci
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Adaptimmune Therapeutics (473A) Moving Averages
MA5
0.01Buy
0.01Sell
MA10
0.01Buy
0.01Sell
MA20
0.01Buy
0.01Sell
MA50
0.01Buy
0.01Sell
MA100
0.01Sell
0.02Sell
MA200
0.02Sell
0.03Sell
Adaptimmune Therapeutics’s (473A) 10-Day exponential moving average is 0.01, while Adaptimmune Therapeutics’s (473A) share price is <€0.1, making it a Sell.
Adaptimmune Therapeutics’s (473A) 100-Day exponential moving average is 0.02, while Adaptimmune Therapeutics’s (473A) share price is <€0.1, making it a Sell.
Adaptimmune Therapeutics’s (473A) stock price is <€0.1 and Adaptimmune Therapeutics’s (473A) 50-day simple moving average is 0.01, creating a Buy signal.
Adaptimmune Therapeutics’s (473A) stock price is <€0.1 and Adaptimmune Therapeutics’s (473A) 100-day simple moving average is 0.01, creating a Sell signal.
Adaptimmune Therapeutics’s (473A) stock price is <€0.1 and Adaptimmune Therapeutics’s (473A) 200-day simple moving average is 0.02, creating a Sell signal.
Adaptimmune Therapeutics (473A) Technical Indicators
RSI (14)
44.83
Neutral
STOCH (9,6)
>-0.01
Buy
STOCHRSI (14)
>-0.01
Buy
MACD (12,26)
>-0.01
Sell
ADX (14)
66.75
Sell
ATR (14)
<0.01
-
Ultimate Oscillator
-595.42
Sell
Bull/Bear Power (13)
>-0.01
Sell
Adaptimmune Therapeutics’s (473A) Relative Strength Index (RSI) is 44.83, creating a Neutral signal.
Adaptimmune Therapeutics’s (473A) Trend Strength Indicator (ADX) is 66.75, creating a Sell signal.
FAQ
Is 473A a Buy, Hold, or Sell?
Based on 473A’s technical indicators, 473A is a Sell.
What is 473A’s RSI (14)?
473A’s RSI (14) is 44.83, which suggests 473A is a Neutral.
What is 473A’s MACD?
473A’s MACD is >-0.01, which suggests 473A is a Sell.
What is 473A’s 5-day moving average?
473A’s 5-day moving average is 0.01, which suggests 473A is a Buy.
What is 473A’s 20-day moving average?
473A 20-day moving average is 0.01, which suggests 473A is a Buy.
What is 473A’s 50-day moving average?
473A’s 50-day moving average is 0.01, which suggests 473A is a Buy.
What is 473A’s 200-day moving average?
473A’s 200-day moving average is 0.02, which suggests 473A is a Sell.
What is 473A’s Williams % R (14)?
Currently, no data Available
What is 473A’s CCI (14)?
473A’s CCI (14) is 0.00, which suggests 473A is a Neutral.
What is the share price of Adaptimmune Therapeutics?